SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 6 — Focused Visit (Care-plan review) — Florence Griffith Joyner

PatientFlorence Griffith Joyner
Date of birth1989-12-21
IdentifiersMRN HR-ML033-SYN; SSN (made up) 000-33-2648
Document date2026-10-20
AuthorCeleste Vanterpool, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Six months after the seizure: seizure freedom, driving review, training, and the long-term plan. [S]

History of Present Illness

Ms. Griffith Joyner returns six and a half months after the seizure on the flight and four months after lesionectomy. She has had no seizure or spell and no detection-watch alert. She takes levetiracetam twice a day and folic acid daily without side effects. She is back to full sprint training, has swum with a companion, and is flying for work again. She has not driven and asks when she can. She is not planning a pregnancy in the next year. She has had no thoughts of self-harm. [S]

ElementDetail
SeizuresNone for six and a half months
TrainingFull sprint training
DrivingNot driving; asks about returning
LevetiracetamTaken as prescribed; no side effects

Review of Systems

SystemResultFinding
ConstitutionalNegativeEnergetic; no weight change
NeurologicalNegativeNo seizures, spells, headache or weakness
MusculoskeletalNegativeTraining without injury
PsychiatricNegativeMood good; PHQ-9 2; no thoughts of self-harm

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Levetiracetam 500 mg oral tablet, one tablet by mouth twice dailyOne tablet twice dailyOral route2026-05-05activeS
Folic acid 0.4 mg oral tablet, one tablet dailyOne tablet dailyOral route2026-05-05activeS
Acetaminophen 500 mg oral tablet, two tablets by mouth every 6 hours as needed for pain after surgery, no more than 3 g a dayTwo tablets every 6 hours as neededOral route2026-06-16 to 2026-06-30completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-10-20Body height170cmS
2026-10-20Body weight60.9kgS
2026-10-20Body mass index (BMI) [Ratio]21.1kg/m2S
2026-10-20Systolic blood pressure110mm[Hg]S
2026-10-20Diastolic blood pressure70mm[Hg]S
2026-10-20Heart rate54/minS
2026-10-20Respiratory rate14/minS
2026-10-20Body temperature36.6CelS
2026-10-20Oxygen saturation in Arterial blood by Pulse oximetry99%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-10-20Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]2{score}S

Physical Exam

Vital signs recorded on 2026-10-20; see the Vital Signs section. [S]

SystemFinding
GeneralFit and well; weight 60.9 kg; blood pressure 110/70, pulse 54
NeurologicalAlert and oriented; cranial nerves, strength, coordination and gait normal
PsychiatricCheerful and engaged

Problems

ProblemClinical statusVerificationCodeProvenance
Generalized tonic-clonic seizure on a flight two and a half weeks ago, in a 36-year-old woman who was observed overnight in hospital elsewhere and has had treatment for seizures in the past, records requested; no antiseizure medication now; normal examination today. Evaluated as a new seizure: EEG and MRI of the brain with susceptibility-weighted imaging ordered, neurology (epilepsy) review booked, and no drivingresolvedconfirmed R56.9S — Synthetic presenting problem anchored to her publicly reported seizure on a flight; superseded by the diagnosis at the epilepsy consultation.
Focal epilepsy with structural cause: focal to bilateral tonic-clonic seizure from a left orbitofrontal cavernous malformation, with left frontal epileptiform discharges on EEG; epilepsy under the ILAE 2014 practical definition (an unprovoked seizure with a recurrence risk above 60% from an epileptogenic lesion, and earlier seizures by history); synthetic modern detail linked to her publicly reported seizures and the coroner's findingactiveconfirmed G40.209S — Synthetic seizure type, EEG and classification; the seizures and the cavernous angioma of the left orbital frontal cerebrum are documented (D).
Solitary cerebral cavernous malformation, 1.4 cm, left orbitofrontal cortex, with a hemosiderin rim and an adjacent developmental venous anomaly, no other lesion on susceptibility-weighted imaging (sporadic pattern); no acute hemorrhageresolvedconfirmed Q28.3S — Synthetic imaging detail; the coroner reported a congenital cavernous angioma of the left orbital frontal cerebrum (D).

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
Self-managementSeizure diary and adherenceEach visitCompleted todayNo seizure for six and a half months; no watch alerts; every dose taken
SurveyMood and behavior on levetiracetam (PHQ-9)Before starting and at each visitCompleted todayPHQ-9 2
Self-managementDriving restriction and the California physician reportUntil cleared by the DMVCompleted todayMedical report sent today, at her request, for the DMV's review
ImagingRepeat MRIAfter complete resection, only for new symptomsNot indicatedComplete resection and no symptoms
ImagingRepeat EEGBefore any taper of antiseizure medicationNot indicatedNo taper is planned for at least two years
Self-managementNocturnal seizure detectionWhile on treatment after recent seizuresCompleted todayContinues by her choice
Self-managementSUDEP risk reviewEach visitCompleted todayNo tonic-clonic seizure for six and a half months, the main protection; she knows the plan
Medication safetyFolic acid, contraception and pregnancy planningEach visitCompleted todayNo pregnancy planned this year; plan with the epilepsy team

Goal progress:

Guideline basis: Krumholz A, et al. Evidence-based guideline: Management of an unprovoked first seizure in adults. Neurology 2015;84(16):1705-1713 (PMID 25901057) (2015); Akers A, et al. Synopsis of Guidelines for the Clinical Management of Cerebral Cavernous Malformations: Consensus Recommendations Based on Systematic Literature Review by the Angioma Alliance Scientific Advisory Board Clinical Experts Panel. Neurosurgery 2017;80(5):665-680 (PMID 28387823) (2017); Harden C, et al. Practice guideline summary: Sudden unexpected death in epilepsy incidence rates and risk factors. Neurology 2017;88(17):1674-1680 (PMID 28438841) (2017); Pack AM, et al. Teratogenesis, Perinatal, and Neurodevelopmental Outcomes After In Utero Exposure to Antiseizure Medication: Practice Guideline From the AAN, AES, and SMFM. Neurology 2024;102(11):e209279 (PMID 38748979) (2024); Beniczky S, et al. Automated seizure detection using wearable devices: A clinical practice guideline of the International League Against Epilepsy and the International Federation of Clinical Neurophysiology. Epilepsia 2021;62(3):632-646 (PMID 33666944) (2021); Governor's message returning Senate Bill 357 without signature (physician reporting of disorders characterized by lapses of consciousness remains mandatory under Health and Safety Code section 103900) (2024); Depression and Suicide Risk in Adults: Screening (2023)

Follow-up: Epilepsy review in six months; primary care preventive visit yearly. Call at once for any seizure; no driving until the DMV clears her. [S]